TARDBP公司
生物
肌萎缩侧索硬化
线粒体DNA
核糖核酸
遗传学
神经科学
计算生物学
基因
医学
SOD1
病理
疾病
突变体
作者
Christoph Schweingruber,Jik Nijssen,Jonas Mechtersheimer,Stefan Reber,Mélanie Lebœuf,Niamh L. O’Brien,Irene Mei,Erin C. Hedges,Michaela Keuper,Julio Aguila Benitez,Vlad Radoi,Martin Jastroch,Marc‐David Ruepp,Eva Hedlund
标识
DOI:10.1038/s41467-025-59679-1
摘要
Abstract Mutations in FUS and TARDBP cause amyotrophic lateral sclerosis (ALS), but the precise mechanisms of selective motor neuron degeneration remain unresolved. To address if pathomechanisms are shared across mutations and related to either gain- or loss-of-function, we performed single-cell RNA sequencing across isogenic induced pluripotent stem cell-derived neuron types, harbouring FUS P525L, FUS R495X, TARDBP M337V mutations or FUS knockout. Transcriptional changes were far more pronounced in motor neurons than interneurons. About 20% of uniquely dysregulated motor neuron transcripts were shared across FUS mutations, half from gain-of-function. Most indicated mitochondrial impairments, with attenuated pathways shared with mutant TARDBP M337V as well as C9orf72-ALS patient motor neurons. Mitochondrial motility was impaired in ALS motor axons, even with nuclear localized FUS mutants, demonstrating shared toxic gain-of-function mechanisms across FUS- and TARDBP-ALS, uncoupled from protein mislocalization. These early mitochondrial dysfunctions unique to motor neurons may affect survival and represent therapeutic targets in ALS.
科研通智能强力驱动
Strongly Powered by AbleSci AI